The Biotechnology Business Institute and Richi Foundation join forces to boost business development in childhood cancer research

Paula Cañal
Jun 5, 2018


As part of its commitment with innovation and entrepreneurship, the Biotechnology Business Institute and Richi Entrepreneurs present the first Childhood Cancer Innovation Award, a charity event in favor of pediatric investigation.

The Summer Charity Cocktail will take place next June 29th, in an unique spot of the coast of Barcelona, which will gather together family, friends, colleagues and professionals of the biopharmaceutical sector to discover the winner between the three projects preselected by an expert jury. The winner company will have the opportunity to travel and meet the city of Boston, owner of one of the most promising innovation hubs in Life Sciences of the world.

The founder of Richi Foundation, Ricard García, currently living in the United States, has expressed his support to the Summer Charity Cocktail and will be present during the event, where García will be part of the expert jury. The candidatures of the three finalist startups from the biotechnology area, Iproteos, BIOGENERA SpA and Parpipred (VHIO), will be valued by an expert jury that will evaluate the innovative nature of the projects and the potential impact in the run against pediatric cancer.

Richi Entrepreneurs, the immersion program of Richi Cildhood Cancer Foundation, is an initiative whose mission is to boost startups from all over the world that have the potential to generate a positive impact on society in the health space, by connecting them with Boston’s innovation key players -industry, investors, hospitals, accelerators, academia and other potential partners- and helping them make the most out of this unique innovation ecosystem.

“The agreement with Richi Foundation is part of one of the main objectives of the Institute. From the academic programs, the Biotechnology Business Institute promotes entrepreneurship and the development of innovative ideas in the biotechnology and biomedicine areas, as well as future leaders in Pharmaceutical and Biotechnology sector”, has expressed Juan R. García, Managing Partner of the Institute.

The award ceremony of the Childhood Cancer Innovation Award is celebrated together with the 5th anniversary of the Biotechnology Business Institute. The business school reaches five years of continuous education of professionals and future leaders of the biotechnology and pharmaceutical sector.

“This event is a great example of how to leverage a special occasion - the 5th anniversary of IEB - to give back to society”, has explained Ernest Lara, Executive Director of Richi Entrepreneurs. “We truly thank the Biotechnology Business Institute for giving us the opportunity of connecting our activity at Richi Entrepreneurs with the original mission of the Richi Childhood Cancer Foundation, by supporting the startup with the highest potential for impact in childhood cancer”. 

Latest news

The first 2019 BioInternational Seminar is a success and gain interest between scientific profiles with vision in drug discovery

International experts shared their experience and knowledge in the pharmaceutical industry and the biotechnology sector over an evening with young scientific profiles developing their career in the drug discovery field

Barcelona has been the first city hosting ENABLE symposium, an European initiative for young scientists included in the “Celebrating European Science” section of the EU’s Horizon 2020 Program

 More than 300 PhD and Postdoctoral students from all over Europe have met in the first European symposium of Biomedicine held in the Palauet Casades, in the centre of Barcelona. The conference, entitled "Breaking down complexity. Innovative models and techniques in Biomedicine" connected the students with new career opportunities in the world of science unexplored for most researchers.

The Biotechnology Business Institute inaugurated the fifth edition of the master’s programs with the consolidation of its innovative educational model, Discover&Transfer

After the success of the first edition of the Discover&Transfer program, the new students of the Biotechnology Business Institute will develop new patents from the main research institutions of Barcelona.

The Biotechnology Business Institute signs a strategic collaboration agreement with IRB Barcelona, the Fundació Bosch i Gimpera and UPF, promoted by UPF Ventures, in a new educational model for drug discovery and technology transfer

The Biotechnology Business Institute (BBI) incorporates Discover & Transfer to the programs, where the students will be working with real drug candidates of these three institutions.

Filter by category